Skip Navigation



European Heart Journal Advance Access published online on August 22, 2007
European Heart Journal, doi:10.1093/eurheartj/ehm170
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/18/2179    most recent
ehm170v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cohen, A.
Right arrow Articles by Boccara, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, A.
Right arrow Articles by Boccara, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism?

Ariel Cohen1,2,*, Stéphane Ederhy1, Catherine Meuleman1, Emanuele DiAngelantonio1, Ghislaine Dufaitre1 and Franck Boccara1

1 Department of Cardiology, Saint-Antoine University and Medical School, Assistance Publique-Hôpitaux de Paris, 184, rue du faubourg St-Antoine, 75571 Paris Cedex 12, France
2 Université Pierre et Marie Curie, Paris, France

* Corresponding author. Tel: +33 1 49 28 28 86; fax: + 33 1 49 28 28 84. E-mail address: ariel.cohen@sat.aphp.fr

This editorial refers to ‘Prediction of left atrial appendage thrombi in nonvalvular atrial fibrillation’ by S. Habara et al., doi:10.1093/eurheartj/ehm356

The first 10% of the full text of this article appears below.

Plasma fibrin D-dimers (hereafter D-dimers) are generated when the endogenous fibrinolytic system degrades fibrin, as in venous thrombo-embolism (VTE) and they consist of two identical subunits derived from two fibrin molecules. Unlike fibrinogen degradation products, which are derived from fibrinogen and fibrin, D-dimers are a specific cross-linked fibrin derivative.1 Because 2–3% of plasma fibrinogen is degraded to fibrin, small amounts are detectable in the plasma of healthy individuals.1 D-dimer levels may be increased in any condition involving the formation and degradation of fibrin, such as VTE, pulmonary embolism, infections, cancer, surgery, cardiac or renal failure, acute coronary syndromes, acute non-lacunar stroke, pregnancy, and sickle cell crises. D-dimer levels increase . . . [Full Text of this Article]

D-dimers in atrial fibrillation

Markers of thrombo-embolism in atrial fibrillation

D-dimers and transeosophageal echocardiography-detected risk markers in atrial fibrillation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?